![Self-driving AI wheelchair edges closer to aiding people with disabilities](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1523550217385_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
With your eyes only
Self-driving AI wheelchair edges closer to aiding people with disabilities
Robot expert’s team has won $50,000 to further develop an eye-controlled, artificially intelligent wheelchair.
Self-driving AI wheelchair edges closer to aiding people with disabilities
Robot expert’s team has won $50,000 to further develop an eye-controlled, artificially intelligent wheelchair.
New class of drugs could help tackle treatment-resistant cancers
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies.
Cybersecurity experts: Device makers have “duty to keep users safe” from hacking
Well-connected smart devices at home and in healthcare are currently vulnerable to hacking, warn two new reports.
Artificial and biological cells work together as mini chemical factories
Researchers have fused living and non-living cells for the first time in a way that allows them to work together, paving the way for new applications.
‘Digistain’ technology offers revolution in detailed cancer diagnosis
New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.
Transatlantic collaborations in molecular science and engineering
Professor Matt Tirrell, Director of the Institute for Molecular Engineering, University of Chicago, visited Imperial last week.
Imperial partners with Agilent to boost molecular research and innovation
A deal has been signed for a suite of equipment that will promote research collaboration at the new Molecular Sciences Research Hub in White City.
Functional nanocoatings for technological and societal applications
The Institute for Molecular Science and Engineering (IMSE) hosted a fascinating Highlight Seminar from Professor Jas Pal Badyal FRS last week.
Fast-acting, readily available gas may mitigate blast-induced brain injury
Treatment with xenon gas after blast reduces blast-induced brain injury, suggests an early-stage study using mouse brain tissue.
Video
AI trial to help accelerate future treatments for Duchenne muscular dystrophy
The Duchenne Research Fund has granted 320,000 pounds to Imperial experts, who hope to help doctors make better treatment decisions for the condition.
3